-
NSE
2,207.00 2,207.00(%) -
SBI
1,159.70 1,234.80(%) -
One 97
1,664.70 947.10(%) -
Billionbrains
218.00 142.05(%) -
LG Electronics
1,725.00 1,835.00(%) -
Bharat Forge
1,734.40 2,293.00(%) -
Maruti Suzuki
13,619.60 17,371.60(%) -
Reliance Industries
1,381.95 1,611.20(%) -
Samvardh. Mothe.
165.00 173.25(%) -
Coforge
2,055.35 2,127.30(%) -
ICICI Bank
1,608.75 1,616.70(%) -
Black Box
933.85 1,104.30(%) -
Bharti Airtel
2,159.95 2,174.70(%) -
Cipla
1,406.95 1,165.55(%) -
M & M
3,524.50 3,840.00(%) -
IndusInd Bank
924.50 1,077.80(%) -
Max Financial
1,383.90 1,173.40(%) -
HDFC Bank
822.10 1,017.90(%) -
Tube Investments
2,247.35 3,335.00(%) -
Mah. Seamless
497.00 493.15(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Aurobindo Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 4666.0
- ISIN : INE406A01037
-
Today’s Low
1,778.00 -
Today’s High
1,805.70
-
Open
1,796.90 -
Perv Close
1,796.30 -
52W Low
1,106.00 -
52W High
1,859.90
Key Indicators
-
P/E(TTM)
37.84
-
Mar.Cap (₹Cr.)
103,895.99
-
Div & Yield %
0.22
-
Book Value(₹)
406.24
-
Debt-Equity Ratio
0.52
-
AGM Date
19-Nov-2026
-
EPS
47.76
-
P/E Ratio
37.84
Financials Ratios
-
Debt-Equity Ratio
0.21
-
Mar.Cap (₹Cr.)
103,895.99
-
RONW (%)
11.18
-
ROCE (%)
13.51
Score Board
-
Equity (₹ in Cr.)
57.54
-
BV (₹)
406.20
-
Sales( ₹ in Cr.)
11,171.72
-
NP (in Cr.)
2,426.73
-
NP Var(%)
39.0
-
Div%
400.0
-
CPS (₹)
47.10
-
EPS (₹)
42.20
-
Traded Value (₹ in Lakhs)
103,970.79
-
52 Week High
1,859.90
-
52 Week Low
1,106.00
-
Price BSE
1807.0
-
Price NSE
1,806.00
-
Market Capital( in Cr.)
103,970.79
-
P/C Ratio
38.30
-
P/E Ratio
42.80
-
Price Vs.BV
42.20
-
05-Nov-2026( 12:21)
Corporate News - Aurob... - <p>Aurobindo Pharma Limited’s...
-
05-Nov-2026( 09:54)
Results - Announcements - Aurob... - <p>Aurobindo Pharma Ltd share...
-
04-Nov-2026( 10:04)
Corporate News - Aurob... - <p>Aurobindo Pharma Limited an...
-
04-Nov-2026( 10:04)
Corporate News - Aurob... - <p>Aurobindo Pharma Limited an...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 11,171.72 | 10,933.30 | 10,645.64 | 8,457.00 | 11,287.14 | 15,823.68 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 11,171.72 | 10,933.30 | 10,645.64 | 8,457.00 | 11,287.14 | 15,823.68 |
| Other Income | 587.53 | 328.12 | 670.10 | 443.92 | 670.99 | 589.86 |
| Stock Adjustments | -46.55 | 67.66 | 116.23 | 263.95 | -45.51 | -2.99 |
| Total Income | 11,712.70 | 11,329.08 | 11,431.97 | 9,164.87 | 11,912.62 | 16,410.55 |
| EXPENDITURE : | ||||||
| Raw Materials | 5,311.58 | 5,675.34 | 5,964.48 | 4,755.95 | 5,800.74 | 7,241.83 |
| Power and Fuel Cost | 174.82 | 185.59 | 191.58 | 167.86 | 477.99 | 512.34 |
| Employee Cost | 1,161.15 | 1,063.07 | 980.56 | 890.53 | 1,600.04 | 1,735.42 |
| Other Manufacturing Expenses | 421.52 | 426.63 | 414.51 | 328.42 | 705.68 | 925.86 |
| Selling and Administration Expenses | 873.42 | 960.27 | 822.21 | 939.38 | 1,009.36 | 1,069.84 |
| Miscellaneous Expenses | 108.12 | 132.49 | 164.49 | 148.96 | 249.13 | 215.57 |
| Employee Benefit Expenses | 1,161.15 | 1,063.07 | 980.56 | 890.53 | 1,600.04 | 1,735.42 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 8,050.61 | 8,443.39 | 8,537.83 | 7,231.10 | 9,842.94 | 11,700.86 |
| Operating Profit | 3,662.09 | 2,885.69 | 2,894.14 | 1,933.77 | 2,069.68 | 4,709.69 |
| Interest | 213.15 | 230.04 | 182.60 | 74.58 | 16.94 | 28.68 |
| Gross Profit | 3,448.94 | 2,655.65 | 2,711.54 | 1,859.19 | 2,052.74 | 4,681.01 |
| Depreciation | 285.36 | 297.20 | 254.58 | 243.26 | 415.26 | 488.00 |
| Profit Before Tax | 3,163.58 | 2,358.45 | 2,456.96 | 1,615.93 | 1,637.48 | 4,193.01 |
| Current Tax | 746.82 | 627.37 | 598.08 | 412.16 | 379.70 | 1,043.34 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.96 | -15.71 | -95.26 | -23.34 | -196.93 | 36.76 |
| Reported Net Profit | 2,414.80 | 1,746.79 | 1,954.14 | 1,227.11 | 1,454.71 | 3,112.91 |
| Extraordinary Items | -11.93 | 5.48 | 3.28 | 9.94 | -81.27 | -0.13 |
| Adjusted Net Profit | 2,426.73 | 1,741.31 | 1,950.86 | 1,217.17 | 1,535.98 | 3,113.04 |
| Adjustment below Net Profit | 1.08 | -5.26 | -1.69 | 8.28 | 1.69 | -6.42 |
| P & L Balance brought forward | 20,090.40 | 18,348.87 | 16,660.08 | 15,864.14 | 14,671.41 | 11,799.30 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 232.30 | 0.00 | 263.66 | 439.45 | 263.67 | 234.38 |
| P & L Balance carried down | 22,273.98 | 20,090.40 | 18,348.87 | 16,660.08 | 15,864.14 | 14,671.41 |
| Dividend | 232.30 | 0.00 | 263.66 | 439.45 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 400.00 | 0.00 | 450.00 | 750.00 | 900.00 | 400.00 |
| Dividend Per Share(Rs) | 4.00 | 0.00 | 4.50 | 7.50 | 9.00 | 4.00 |
| Earnings Per Share-Unit Curr | 41.58 | 30.08 | 33.35 | 20.94 | 24.83 | 53.13 |
| Earnings Per Share(Adj)-Unit Curr | 41.58 | 30.08 | 33.35 | 20.94 | 24.83 | 53.13 |
| Book Value | 391.14 | 353.55 | 336.62 | 307.80 | 292.15 | 271.80 |
| Book Value(Adj)-Unit Curr | 391.14 | 353.55 | 336.62 | 307.80 | 292.15 | 271.80 |
